Han, Pinsheng
Zhu, Liuyang
Tong, Wen
Liu, Sen
Xu, Yongdeng
Wang, Libo
Wang, Tianze
Zhao, Tianyu
Miao, Yu
Chi, Hao
Cui, Tao
Wang, Ze
Yang, Long
Zhang, Yamin
Funding for this research was provided by:
State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine project (712023001;712023002;712024001)
Project of Science and Technology Program of Tianjin (24ZXZSSS00480, 24ZYCGSY00640)
CAMS Innovation Fund for Medical Sciences (2019-I2M-5-020)
Tianjin Health Science and Technology Project (TJWJ2023QN034)
Tianjin Science and Technology Project (24JCYBJC01840)
National Natural Science Foundation of China (82372194 and 82204546)
Article History
Received: 16 November 2024
Accepted: 21 December 2025
First Online: 31 December 2025
Declarations
:
: Ethics approval and consent to participate all procedures performed in this study involving human participants and animals were approved by the Ethics Committee of the Tianjin First Central Hospital and Tianjin Tian Cheng New Drug Evaluation Co., Ltd. Written informed consent was signed by each patient.
: The authors declare no competing interests.